Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells

Seminars in Immunology

Volumn 35, Issue , 2018, Pages 19-28

  Zhou, Jie ^a,b   Nefedova, Yulia ^c   Lei, Aihua ^a,b   Gabrilovich, Dmitry ^a,b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c WISTAR INSTITUTE   (United States)

Author keywords

Cancer; Fibroblasts; Infectious diseases; Myeloid derived suppressor cells; Neutrophils

Indexed keywords

ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; HUMAN; INFECTION; LEUKOCYTE FUNCTION; MALIGNANT NEOPLASM; META ANALYSIS (TOPIC); MYELOID-DERIVED SUPPRESSOR CELL; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; REVIEW; SEPSIS; STROMA CELL; ANIMAL; CELL COMMUNICATION; CELLULAR IMMUNITY; COMMUNICABLE DISEASE; IMMUNOLOGY; IMMUNOMODULATION; NEOPLASM;

ANIMALS; CELL COMMUNICATION; COMMUNICABLE DISEASES; HUMANS; IMMUNITY, CELLULAR; IMMUNOMODULATION; MYELOID-DERIVED SUPPRESSOR CELLS; NEOPLASMS; NEUTROPHILS; STROMAL CELLS;

EID: 85039417778     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2017.12.004     Document Type: Review

References (196)

1. Ost, M., Singh, A., Peschel, A., Mehling, R., Rieber, N., Hartl, D., Myeloid-Derived suppressor cells in bacterial infections. Front. Cell. Infect. Microbiol., 6, 2016, 37.
2. Brandau, S., Moses, K., Lang, S., The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: Cousins, siblings or twins?. Semin. Cancer Biol. 23:3 (2013), 171–182.
3. Gabrilovich, D.I., Myeloid-Derived suppressor cells. Cancer Immunol. Res. 5:1 (2017), 3–8.
4. Gabrilovich, D.I., Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:3 (2009), 162–174.
5. Mantovani, A., Cassatella, M.A., Costantini, C., Jaillon, S., Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11:8 (2011), 519–531.
6. Kobayashi, S.D., DeLeo, F.R., Role of neutrophils in innate immunity: a systems biology-level approach: wiley interdisciplinary reviews. Syst. Biol. Med. 1:3 (2009), 309–333.
7. Coffelt, S.B., Wellenstein, M.D., de Visser, K.E., Neutrophils in cancer: neutral no more. Nat. Rev. Cancer 16:7 (2016), 431–446.
8. Borregaard, N., Neutrophils, from marrow to microbes. Immunity 33:5 (2010), 657–670.
9. Hager, M., Cowland, J.B., Borregaard, N., Neutrophil granules in health and disease. J. Intern. Med. 268:1 (2010), 25–34.
10. Borregaard, N., Sorensen, O.E., Theilgaard-Monch, K., Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28:8 (2007), 340–345.
11. Furze, R.C., Rankin, S.M., The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. FASEB J. 22:9 (2008), 3111–3119.
12. Stark, M.A., Huo, Y., Burcin, T.L., Morris, M.A., Olson, T.S., Ley, K., Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22:3 (2005), 285–294.
13. Roberts, A.W., G-CSF: a key regulator of neutrophil production, but that's not all!. Growth Factors (Chur, Switzerland) 23:1 (2005), 33–41.
14. Bugl, S., Wirths, S., Muller, M.R., Radsak, M.P., Kopp, H.G., Current insights into neutrophil homeostasis. Ann. N. Y. Acad. Sci. 1266 (2012), 171–178.
15. Lieschke, G.J., Grail, D., Hodgson, G., Metcalf, D., Stanley, E., Cheers, C., Fowler, K.J., Basu, S., Zhan, Y.F., Dunn, A.R., Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:6 (1994), 1737–1746.
16. Molineux, G., Migdalska, A., Szmitkowski, M., Zsebo, K., Dexter, T.M., The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:4 (1991), 961–966.
17. Liu, F., Poursine-Laurent, J., Wu, H.Y., Link, D.C., Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood 90:7 (1997), 2583–2590.
18. Seymour, J.F., Lieschke, G.J., Grail, D., Quilici, C., Hodgson, G., Dunn, A.R., Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90:8 (1997), 3037–3049.
19. Eash, K.J., Means, J.M., White, D.W., Link, D.C., CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood 113:19 (2009), 4711–4719.
20. Eash, K.J., Greenbaum, A.M., Gopalan, P.K., Link, D.C., CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest. 120:7 (2010), 2423–2431.
21. Kim, H.K., De La Luz Sierra, M., Williams, C.K., Gulino, A.V., Tosato, G., G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood 108:3 (2006), 812–820.
22. Bronte, V., Brandau, S., Chen, S.H., Colombo, M.P., Frey, A.B., Greten, T.F., Mandruzzato, S., Murray, P.J., Ochoa, A., Ostrand-Rosenberg, S., Rodriguez, P.C., Sica, A., Umansky, V., Vonderheide, R.H., Gabrilovich, D.I., Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun., 7, 2016, 12150.
23. Moses, K., Brandau, S., Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin. Immunol. 28:2 (2016), 187–196.
24. Kotsakis, A., Harasymczuk, M., Schilling, B., Georgoulias, V., Argiris, A., Whiteside, T.L., Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J. Immunol. Methods 381:1–2 (2012), 14–22.
25. Youn, J.I., Collazo, M., Shalova, I.N., Biswas, S.K., Gabrilovich, D.I., Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91:1 (2012), 167–181.
26. Condamine, T., Dominguez, G.A., Youn, J. I, Kossenkov, A.V., Mony, S., Alicea-Torres, K., Tcyganov, E., Hashimoto, A., Nefedova, Y., Lin, C., Partlova, S., Garfall, A., Vogl, D.T., Xu, X., Knight, S.C., Malietzis, G., Lee, G.H., Eruslanov, E., Albelda, S.M., Wang, X., Mehta, J.L., Bewtra, M., Rustgi, A., Hockstein, N., Witt, R., Masters, G., Nam, B., Smirnov, D., Sepulveda, M.A., Gabrilovich, D.I., Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci. Immunol., 1(2), 2016.
27. Gabrilovich, D.I., Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:3 (2009), 162–174.
28. Ostrand-Rosenberg, S., Sinha, P., Beury, D.W., Clements, V.K., Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin. Cancer Biol. 22:4 (2012), 275–281.
29. Sinha, P., Clements, V.K., Bunt, S.K., Albelda, S.M., Ostrand-Rosenberg, S., Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179:2 (2007), 977–983.
30. Gato, M., Blanco-Luquin, I., Zudaire, M., de Morentin, X.M., Perez-Valderrama, E., Zabaleta, A., Kochan, G., Escors, D., Fernandez-Irigoyen, J., Santamaria, E., Drafting the proteome landscape of myeloid-derived suppressor cells. Proteomics 16:2 (2016), 367–378.
31. Gato-Canas, M., Martinez de Morentin, X., Blanco-Luquin, I., Fernandez-Irigoyen, J., Zudaire, I., Liechtenstein, T., Arasanz, H., Lozano, T., Casares, N., Chaikuad, A., Knapp, S., Guerrero-Setas, D., Escors, D., Kochan, G., Santamaria, E., A core of kinase-regulated interactomes defines the neoplastic MDSC lineage. Oncotarget 6:29 (2015), 27160–27175.
32. Fridlender, Z.G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G.S., Albelda, S.M., Transcriptomic analysis comparing tumor-Associated neutrophils with granulocytic myeloid-Derived suppressor cells and normal neutrophils. PLoS One, 7(2), 2012.
33. Brandau, S., Trellakis, S., Bruderek, K., Schmaltz, D., Steller, G., Elian, M., Suttmann, H., Schenck, M., Welling, J., Zabel, P., Lang, S., Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J. Leukoc. Biol. 89:2 (2011), 311–317.
34. Gabrilovich, D.I., Nagaraj, S., Myeloid-derived-suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:3 (2009), 162–174.
35. Mattei, F., Schiavoni, G., Sestili, P., Spadaro, F., Fragale, A., Sistigu, A., Lucarini, V., Spada, M., Sanchez, M., Scala, S., Battistini, A., Belardelli, F., Gabriele, L., IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment. Neoplasia 14:12 (2012), 1223–1235.
36. Paschall, A.V., Zhang, R., Qi, C.F., Bardhan, K., Peng, L., Lu, G., Yang, J., Merad, M., McGaha, T., Zhou, G., Mellor, A., Abrams, S.I., Morse, H.C. 3rd, Ozato, K., Xiong, H., Liu, K., IFN regulatory factor 8 represses GM-CSF expression in t cells to affect myeloid cell lineage differentiation. J. Immunol. 194:5 (2015), 2369–2379.
37. Waight, J.D., Netherby, C., Hensen, M.L., Miller, A., Hu, Q., Liu, S., Bogner, P.N., Farren, M.R., Lee, K.P., Liu, K., Abrams, S.I., Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. J. Clin. Invest. 123:10 (2013), 4464–4478.
38. Netherby, C.S., Messmer, M.N., Burkard-Mandel, L., Colligan, S., Miller, A., Cortes Gomez, E., Wang, J., Nemeth, M.J., Abrams, S.I., The granulocyte progenitor stage is a key target of IRF8-Mediated regulation of myeloid-Derived suppressor cell production. J. Immunol. 198:10 (2017), 4129–4139.
39. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., Calabrese, F., Basso, G., Zanovello, P., Cozzi, E., Mandruzzato, S., Bronte, V., Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32:6 (2010), 790–802.
40. Rodriguez, P.C., Hernandez, C.P., Quiceno, D., Dubinett, S.M., Zabaleta, J., Ochoa, J.B., Gilbert, J., Ochoa, A.C., Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 202:7 (2005), 931–939.
41. Donkor, M.K., Lahue, E., Hoke, T.A., Shafer, L.R., Coskun, U., Solheim, J.C., Gulen, D., Bishay, J., Talmadge, J.E., Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int. Immunopharmacol. 9:7–8 (2009), 937–948.
42. Mao, Y., Poschke, I., Wennerberg, E., Pico de Coana, Y., Egyhazi Brage, S., Schultz, I., Hansson, J., Masucci, G., Lundqvist, A., Kiessling, R., Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Res. 73:13 (2013), 3877–3887.
43. Hammami, I., Chen, J., Murschel, F., Bronte, V., De Crescenzo, G., Jolicoeur, M., Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models. BMC Cell Biol., 13, 2012, 18.
44. Hossain, F., Al-Khami, A.A., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Valle, L.D., Trillo-Tinoco, J., Maj, T., Zou, W., Rodriguez, P.C., Ochoa, A.C., Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-Derived suppressor cells and enhances cancer therapies. Cancer Immunol. Res. 3:11 (2015), 1236–1247.
45. Condamine, T., Kumar, V., Ramachandran, I.R., Youn, J.I., Celis, E., Finnberg, N., El-Deiry, W.S., Winograd, R., Vonderheide, R.H., English, N.R., Knight, S.C., Yagita, H., McCaffrey, J.C., Antonia, S., Hockstein, N., Witt, R., Masters, G., Bauer, T., Gabrilovich, D.I., ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J. Clin. Invest. 124:6 (2014), 2626–2639.
46. Thevenot, P.T., Sierra, R.A., Raber, P.L., Al-Khami, A.A., Trillo-Tinoco, J., Zarreii, P., Ochoa, A.C., Cui, Y., Del Valle, L., Rodriguez, P.C., The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors. Immunity 41:3 (2014), 389–401.
47. Gabrilovich, D.I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12:4 (2012), 253–268.
48. Parkos, C.A., Neutrophil-Epithelial interactions a double-Edged sword. Am. J. Pathol. 186:6 (2016), 1404–1416.
49. Ley, K., Laudanna, C., Cybulsky, M.I., Nourshargh, S., Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:9 (2007), 678–689.
50. Schmidt, S., Moser, M., Sperandio, M., The molecular basis of leukocyte recruitment and its deficiencies. Mol. Immunol. 55:1 (2013), 49–58.
51. Muller, W.A., Getting leukocytes to the site of inflammation. Vet. Pathol. 50:1 (2013), 7–22.
52. Sundd, P., Pospieszalska, M.K., Ley, K., Neutrophil rolling at high shear: flattening, catch bond behavior, tethers and slings. Mol. Immunol. 55:1 (2013), 59–69.
53. Jerke, U., Rolle, S., Purfurst, B., Luft, F.C., Nauseef, W.M., Kettritz, R., beta2 integrin-mediated cell–cell contact transfers active myeloperoxidase from neutrophils to endothelial cells. J. Biol. Chem. 288:18 (2013), 12910–12919.
54. Yuan, S.Y., Shen, Q., Rigor, R.R., Wu, M.H., Neutrophil transmigration, focal adhesion kinase and endothelial barrier function. Microvasc. Res. 83:1 (2012), 82–88.
55. Kuckleburg, C.J., Newman, P.J., Neutrophil proteinase 3 acts on protease-activated receptor-2 to enhance vascular endothelial cell barrier function. Arterioscler. Thromb. Vasc. Biol. 33:2 (2013), 275–284.
56. Gautam, N., Olofsson, A.M., Herwald, H., Iversen, L.F., Lundgren-Akerlund, E., Hedqvist, P., Arfors, K.E., Flodgaard, H., Lindbom, L., Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat. Med. 7:10 (2001), 1123–1127.
57. Boueiz, A., Hassoun, P.M., Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc. Res. 77:1 (2009), 26–34.
58. Pitanga, T.N., de Aragao Franca, L., Rocha, V.C., Meirelles, T., Borges, V.M., Goncalves, M.S., Pontes-de-Carvalho, L.C., Noronha-Dutra, A.A., W.L. dos-Santos Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells. BMC Cell Biol., 15, 2014, 21.
59. Slater, T.W., Finkielsztein, A., Mascarenhas, L.A., Mehl, L.C., Butin-Israeli, V., Sumagin, R., Neutrophil microparticles deliver active myeloperoxidase to injured mucosa to inhibit epithelial wound healing. J. Immunol.(Baltimore, Md.: 1950) 198:7 (2017), 2886–2897.
60. Chrysanthopoulou, A., Mitroulis, I., Apostolidou, E., Arelaki, S., Mikroulis, D., Konstantinidis, T., Sivridis, E., Koffa, M., Giatromanolaki, A., Boumpas, D.T., Ritis, K., Kambas, K., Neutrophil extracellular traps promote differentiation and function of fibroblasts. J. Pathol. 233:3 (2014), 294–307.
61. Gregory, A.D., Kliment, C.R., Metz, H.E., Kim, K.H., Kargl, J., Agostini, B.A., Crum, L.T., Oczypok, E.A., Oury, T.A., Houghton, A.M., Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis. J. Leukoc. Biol. 98:2 (2015), 143–152.
62. Wu, Y., Li, Y., Zhang, C., Wang, X.A.Y., Cui, W., Li, H., Du, J., S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury. Hypertension 63:6 (2014), 1241–1250.
63. Kumar, V., Donthireddy, L., Marvel, D., Condamine, T., Wang, F., Lavilla-Alonso, S., Hashimoto, A., Vonteddu, P., Behera, R., Goins, M.A., Mulligan, C., Nam, B., Hockstein, N., Denstman, F., Shakamuri, S., Speicher, D.W., Weeraratna, A.T., Chao, T., Vonderheide, R.H., Languino, L.R., Ordentlich, P., Liu, Q., Xu, X., Lo, A., Puré E., Zhang, C., Loboda, A., Sepulveda, M.A., Snyder, L.A., Gabrilovich, D.I., Cancer-Associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors. Cancer Cell 32:5 (2017), 654–668.
64. Templeton, A.J., Pezaro, C., Omlin, A., McNamara, M.G., Leibowitz-Amit, R., Vera-Badillo, F.E., Attard, G., de Bono, J.S., Tannock, I.F., Amir, E., Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio. Cancer 120:21 (2014), 3346–3352.
65. Keizman, D., Gottfried, M., Ish-Shalom, M., Maimon, N., Peer, A., Neumann, A., Rosenbaum, E., Kovel, S., Pili, R., Sinibaldi, V., Carducci, M.A., Hammers, H., Eisenberger, M.A., Sella, A., Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram. Oncologist 17:12 (2012), 1508–1514.
66. Keizman, D., Ish-Shalom, M., Huang, P., Eisenberger, M.A., Pili, R., Hammers, H., Carducci, M.A., The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur. J. Cancer (Oxford, England : 1990) 48:2 (2012), 202–208.
67. Galdiero, M.R., Garlanda, C., Jaillon, S., Marone, G., Mantovani, A., Tumor associated macrophages and neutrophils in tumor progression. J. Cell. Physiol. 228:7 (2013), 1404–1412.
68. Elpek, K.G., Cremasco, V., Shen, H., Harvey, C.J., Wucherpfennig, K.W., Goldstein, D.R., Monach, P.A., Turley, S.J., The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells. Cancer Immunol. Res. 2:7 (2014), 655–667.
69. Brandau, S., Dumitru, C.A., Lang, S., Protumor and antitumor functions of neutrophil granulocytes. Semin. Immunopathol. 35:2 (2013), 163–176.
70. Mantovani, A., Cassatella, M.A., Costantini, C., Jaillon, S., Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11:8 (2011), 519–531.
71. Blaisdell, A., Crequer, A., Columbus, D., Daikoku, T., Mittal, K., Dey, S.K., Erlebacher, A., Neutrophils oppose uterine epithelial carcinogenesis via debridement of hypoxic tumor cells. Cancer Cell 28:6 (2015), 785–799.
72. Finisguerra, V., Di Conza, G., Di Matteo, M., Serneels, J., Costa, S., Thompson, A.A., Wauters, E., Walmsley, S., Prenen, H., Granot, Z., Casazza, A., Mazzone, M., MET is required for the recruitment of anti-tumoural neutrophils. Nature 522:7556 (2015), 349–353.
73. Glodde, N., Bald, T., van den Boorn-Konijnenberg, D., Nakamura, K., O'Donnell, J.S., Szczepanski, S., Brandes, M., Eickhoff, S., Das, I., Shridhar, N., Hinze, D., Rogava, M., van der Sluis, T.C., Ruotsalainen, J.J., Gaffal, E., Landsberg, J., Ludwig, K.U., Wilhelm, C., Riek-Burchardt, M., Muller, A.J., Gebhardt, C., Scolyer, R.A., Long, G.V., Janzen, V., Teng, M.W.L., Kastenmuller, W., Mazzone, M., Smyth, M.J., Tuting, T., Holzel, M., Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy. Immunity 47:4 (2017), 789–802 (e9).
74. Granot, Z., Henke, E., Comen, E.A., King, T.A., Norton, L., Benezra, R., Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20:3 (2011), 300–314.
75. Lopez-Lago, M.A., Posner, S., Thodima, V.J., Molina, A.M., Motzer, R.J., Chaganti, R.S., Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 32:14 (2013), 1752–1760.
76. Catena, R., Bhattacharya, N., El Rayes, T., Wang, S., Choi, H., Gao, D., Ryu, S., Joshi, N., Bielenberg, D., Lee, S.B., Haukaas, S.A., Gravdal, K., Halvorsen, O.J., Akslen, L.A., Watnick, R.S., Mittal, V., Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1. Cancer Discov. 3:5 (2013), 578–589.
77. El Rayes, T., Catena, R., Lee, S., Stawowczyk, M., Joshi, N., Fischbach, C., Powell, C.A., Dannenberg, A.J., Altorki, N.K., Gao, D., Mittal, V., Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1. Proc. Natl. Acad. Sci. U. S. A. 112:52 (2015), 16000–16005.
78. Sconocchia, G., Zlobec, I., Lugli, A., Calabrese, D., Iezzi, G., Karamitopoulou, E., Patsouris, E.S., Peros, G., Horcic, M., Tornillo, L., Zuber, M., Droeser, R., Muraro, M.G., Mengus, C., Oertli, D., Ferrone, S., Terracciano, L., Spagnoli, G.C., Tumor infiltration by FcgammaRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int. J. Cancer 128:11 (2011), 2663–2672.
79. Droeser, R.A., Hirt, C., Eppenberger-Castori, S., Zlobec, I., Viehl, C.T., Frey, D.M., Nebiker, C.A., Rosso, R., Zuber, M., Amicarella, F., Iezzi, G., Sconocchia, G., Heberer, M., Lugli, A., Tornillo, L., Oertli, D., Terracciano, L., Spagnoli, G.C., High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One, 8(5), 2013, e64814.
80. Treffers, L.W., Hiemstra, I.H., Kuijpers, T.W., van den Berg, T.K., Matlung, H.L., Neutrophils in cancer. Immunol. Rev. 273:1 (2016), 312–328.
81. Jamieson, T., Clarke, M., Steele, C.W., Samuel, M.S., Neumann, J., Jung, A., Huels, D., Olson, M.F., Das, S., Nibbs, R.J.B., Sansom, O.J., Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122:9 (2012), 3127–3144.
82. Katoh, H., Wang, D.Z., Daikoku, T., Sun, H.Y., Dey, S.K., DuBois, R.N., CXCR2-Expressing myeloid-Derived suppressor cells are essential to promote colitis-Associated tumorigenesis. Cancer Cell 24:5 (2013), 631–644.
83. Shang, K., Bai, Y.P., Wang, C., Wang, Z., Gu, H.Y., Du, X., Zhou, X.Y., Zheng, C.L., Chi, Y.Y., Mukaida, N., Li, Y.Y., Crucial involvement of tumor-Associated neutrophils in the regulation of chronic colitis-Associated carcinogenesis in mice. PLoS One, 7(12), 2012.
84. Spicer, J.D., McDonald, B., Cools-Lartigue, J.J., Chow, S.C., Giannias, B., Kubes, P., Ferri, L.E., Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Res. 72:16 (2012), 3919–3927.
85. Tazawa, H., Okada, F., Kobayashi, T., Tada, M., Mori, Y., Une, Y., Sendo, F., Kobayashi, M., Hosokawa, M., Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am. J. Pathol. 163:6 (2003), 2221–2232.
86. Antonio, N., Bonnelykke-Behrndtz, M.L., Ward, L.C., Collin, J., Christensen, I.J., Steiniche, T., Schmidt, H., Feng, Y., Martin, P., The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J. 34:17 (2015), 2219–2236.
87. Houghton, A.M., Rzymkiewicz, D.M., Ji, H., Gregory, A.D., Egea, E.E., Metz, H.E., Stolz, D.B., Land, S.R., Marconcini, L.A., Kliment, C.R., Jenkins, K.M., Beaulieu, K.A., Mouded, M., Frank, S.J., Wong, K.K., Shapiro, S.D., Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 16:2 (2010), 219–223.
88. Tazzyman, S., Barry, S.T., Ashton, S., Wood, P., Blakey, D., Lewis, C.E., Murdoch, C., Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth. Int. J. Cancer 129:4 (2011), 847–858.
89. Yang, L., DeBusk, L.M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L.M., Carbone, D.P., Lin, P.C., Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6:4 (2004), 409–421.
90. Di Mitri, D., Toso, A., Chen, J.J., Sarti, M., Pinton, S., Jost, T.R., D'Antuono, R., Montani, E., Garcia-Escudero, R., Guccini, I., Da Silva-Alvarez, S., Collado, M., Eisenberger, M., Zhang, Z., Catapano, C., Grassi, F., Alimonti, A., Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature 515:7525 (2014), 134–137.
91. Nozawa, H., Chiu, C., Hanahan, D., Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 103:33 (2006), 12493–12498.
92. Coussens, L.M., Tinkle, C.L., Hanahan, D., Werb, Z., MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:3 (2000), 481–490.
93. Shojaei, F., Singh, M., Thompson, J.D., Ferrara, N., Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl. Acad. Sci. U. S. A. 105:7 (2008), 2640–2645.
94. Bald, T., Quast, T., Landsberg, J., Rogava, M., Glodde, N., Lopez-Ramos, D., Kohlmeyer, J., Riesenberg, S., van den Boorn-Konijnenberg, D., Homig-Holzel, C., Reuten, R., Schadow, B., Weighardt, H., Wenzel, D., Helfrich, I., Schadendorf, D., Bloch, W., Bianchi, M.E., Lugassy, C., Barnhill, R.L., Koch, M., Fleischmann, B.K., Forster, I., Kastenmuller, W., Kolanus, W., Holzel, M., Gaffal, E., Tuting, T., Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507:7490 (2014), 109–113.
95. Yan, H.H., Pickup, M., Pang, Y., Gorska, A.E., Li, Z., Chytil, A., Geng, Y., Gray, J.W., Moses, H.L., Yang, L., Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 70:15 (2010), 6139–6149.
96. Wculek, S.K., Malanchi, I., Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528:7582 (2015), 413–417.
97. Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., Ferri, L., Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest., 2013.
98. Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., Ferri, L., Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest., 2013.
99. Condamine, T., Ramachandran, I., Youn, J.I., Gabrilovich, D.I., Regulation of tumor metastasis by myeloid-Derived suppressor cells. Annu. Rev. Med. 66:66 (2015), 97–110.
100. Umansky, V., Blattner, C., Gebhardt, C., Utikal, J., The role of myeloid-Derived suppressor cells (MDSC) in cancer progression. Vaccines, 4(4), 2016.
101. Kusmartsev, S., Eruslanov, E., Kubler, H., Tseng, T., Sakai, Y., Su, Z., Kaliberov, S., Heiser, A., Rosser, C., Dahm, P., Siemann, D., Vieweg, J., Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. J. Immunol. 181:1 (2008), 346–353.
102. Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.H., Yao, J., Blanchard, D., Bais, C., Peale, F.V., van Bruggen, N., Ho, C., Ross, J., Tan, M., Carano, R.A., Meng, Y.G., Ferrara, N., Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450:7171 (2007), 825–831.
103. Kowanetz, M., Wu, X., Lee, J., Tan, M., Hagenbeek, T., Qu, X., Yu, L., Ross, J., Korsisaari, N., Cao, T., Bou-Reslan, H., Kallop, D., Weimer, R., Ludlam, M.J., Kaminker, J.S., Modrusan, Z., van Bruggen, N., Peale, F.V., Carano, R., Meng, Y.G., Ferrara, N., Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G + Ly6C+ granulocytes. Proc. Natl. Acad. Sci. U. S. A. 107:50 (2010), 21248–21255.
104. Pan, P.Y., Wang, G.X., Yin, B., Ozao, J., Ku, T., Divino, C.M., Chen, S.H., Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood 111:1 (2008), 219–228.
105. Finke, J., Ko, J., Rini, B., Rayman, P., Ireland, J., Cohen, P., MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. Int. Immunopharmacol. 11:7 (2011), 856–861.
106. Yang, L., Huang, J., Ren, X., Gorska, A.E., Chytil, A., Aakre, M., Carbone, D.P., Matrisian, L.M., Richmond, A., Lin, P.C., Moses, H.L., Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13:1 (2008), 23–35.
107. Wei, W.C., Lin, S.Y., Lan, C.W., Huang, Y.C., Lin, C.Y., Hsiao, P.W., Chen, Y.R., Yang, W.C., Yang, N.S., Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis. Sci. Rep., 6, 2016, 36663.
108. Deng, Z., Rong, Y., Teng, Y., Zhuang, X., Samykutty, A., Mu, J., Zhang, L., Cao, P., Yan, J., Miller, D., Zhang, H.G., Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis. Oncogene 36:5 (2017), 639–651.
109. Sawanobori, Y., Ueha, S., Kurachi, M., Shimaoka, T., Talmadge, J.E., Abe, J., Shono, Y., Kitabatake, M., Kakimi, K., Mukaida, N., Matsushima, K., Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111:12 (2008), 5457–5466.
110. Sceneay, J., Chow, M.T., Chen, A., Halse, H.M., Wong, C.S., Andrews, D.M., Sloan, E.K., Parker, B.S., Bowtell, D.D., Smyth, M.J., Moller, A., Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 72:16 (2012), 3906–3911.
111. Cui, T.X., Kryczek, I., Zhao, L., Zhao, E., Kuick, R., Roh, M.H., Vatan, L., Szeliga, W., Mao, Y., Thomas, D.G., Kotarski, J., Tarkowski, R., Wicha, M., Cho, K., Giordano, T., Liu, R., Zou, W., Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity 39:3 (2013), 611–621.
112. Toh, B., Wang, X., Keeble, J., Sim, W.J., Khoo, K., Wong, W.C., Kato, M., Prevost-Blondel, A., Thiery, J.P., Abastado, J.P., Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol., 9(9), 2011, e1001162.
113. Templeton, A.J., McNamara, M.G., Seruga, B., Vera-Badillo, F.E., Aneja, P., Ocana, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J.J., Tran, B., Tannock, I.F., Amir, E., Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst., 106(6), 2014, dju124.
114. Zhang, G.M., Zhu, Y., Ma, X.C., Qin, X.J., Wan, F.N., Dai, B., Sun, L.J., Ye, D.W., Pretreatment neutrophil-to-Lymphocyte ratio: a predictor of advanced prostate cancer and biochemical recurrence in patients receiving radical prostatectomy. Medicine (Baltimore)., 94(41), 2015, e1473.
115. Piccard, H., Muschel, R.J., Opdenakker, G., On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit. Rev. Oncol. Hematol. 82:3 (2012), 296–309.
116. Yu, Y., Qian, L., Cui, J., Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: a meta-analysis of 7,219 patients. Mol. Clin. Oncol. 7:3 (2017), 498–506.
117. Chen, S., Zhang, L., Yan, G., Cheng, S., Fathy, A.H., Yan, N., Zhao, Y., Neutrophil-to-Lymphocyte ratio is a potential prognostic biomarker in patients with ovarian cancer: a meta-Analysis. BioMed Res. Int., 2017, 2017, 7943467.
118. Jensen, H.K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., von der Maase, H., Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27:28 (2009), 4709–4717.
119. Jensen, T.O., Schmidt, H., Moller, H.J., Donskov, F., Hoyer, M., Sjoegren, P., Christensen, I.J., Steiniche, T., Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer 118:9 (2012), 2476–2485.
120. Carus, A., Ladekarl, M., Hager, H., Pilegaard, H., Nielsen, P.S., Donskov, F., Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome. Lung Cancer 81:1 (2013), 130–137.
121. Yang, G., Shen, W., Zhang, Y., Liu, M., Zhang, L., Liu, Q., Lu, H.H., Bo, J., Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer. Oncotarget 8:24 (2017), 38378–38388.
122. Li, X., Xing, Y.F., Lei, A.H., Xiao, Q., Lin, Z.H., Hong, Y.F., Wu, X.Y., Zhou, J., Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients. Oncotarget 8:15 (2017), 24380–24388.
123. Gabitass, R.F., Annels, N.E., Stocken, D.D., Pandha, H.A., Middleton, G.W., Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol. Immunother. 60:10 (2011), 1419–1430.
124. Diaz-Montero, C.M., Salem, M.L., Nishimura, M.I., Garrett-Mayer, E., Cole, D.J., Montero, A.J., Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 58:1 (2009), 49–59.
125. Achberger, S., Aldrich, W., Tubbs, R., Crabb, J.W., Singh, A.D., Triozzi, P.L., Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol. Immunol. 58:2 (2014), 182–186.
126. Li, J., Srivastava, R.M., Ettyreddy, A., Ferris, R.L., Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients. J. Immunother. Cancer, 3, 2015, 54.
127. Mandruzzato, S., Brandau, S., Britten, C.M., Bronte, V., Damuzzo, V., Gouttefangeas, C., Maurer, D., Ottensmeier, C., Burg, S.H., Welters, M.J.P., Walter, S., Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study. Cancer Immunol. Immunother. 65:2 (2016), 161–169.
128. Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S.M., Vincent, J.-L., Ramsay, G.C., International sepsis definitions, 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 29:4 (2003), 530–538.
129. Viale, P., Tedeschi, S., Scudeller, L., Attard, L., Badia, L., Bartoletti, M., Cascavilla, A., Cristini, F., Dentale, N., Fasulo, G., Legnani, G., Trapani, F., Tumietto, F., Verucchi, G., Virgili, G., Berlingeri, A., Ambretti, S., De Molo, C., Brizi, M., Cavazza, M., Giannella, M., Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department. Clin. Infectious Dis. 65:8 (2017), 1253–1259.
130. Alves-Filho, J.C., de Freitas, A., Spiller, F., Souto, F.O., Cunha, F.Q., The role of neutrophils in severe sepsis. Shock (Augusta, Ga.) 30:Suppl 1 (2008), 3–9.
131. Craciun, F.L., Schuller, E.R., Remick, D.G., Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. J. Immunol. (Baltimore, Md.: 1950) 185:11 (2010), 6930–6938.
132. Kasten, K.R., Muenzer, J.T., Caldwell, C.C., Neutrophils are significant producers of IL-10 during sepsis. Biochem. Biophys. Res. Commun. 393:1 (2010), 28–31.
133. Delano, M.J., Thayer, T., Gabrilovich, S., Kelly-Scumpia, K.M., Winfield, R.D., Scumpia, P.O., Cuenca, A.G., Warner, E., Wallet, S.M., Wallet, M.A., O'Malley, K.A., Ramphal, R., Clare-Salzer, M., Efron, P.A., Mathews, C.E., Moldawer, L.L., Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J. Immunol. 186:1 (2011), 195–202.
134. Paunel-Gorgulu, A., Kirichevska, T., Logters, T., Windolf, J., Flohe, S., Molecular mechanisms underlying delayed apoptosis in neutrophils from multiple trauma patients with and without sepsis. Mol. Med. (Cambridge, Mass.) 18 (2012), 325–335.
135. McDonald, B., Urrutia, R., Yipp, B.G., Jenne, C.N., Kubes, P., Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12:3 (2012), 324–333.
136. Parker, H., Albrett, A.M., Kettle, A.J., Winterbourn, C.C., Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J. Leukoc. Biol. 91:3 (2012), 369–376.
137. Berends, E.T.M., Horswill, A.R., Haste, N.M., Monestier, M., Nizet, V., von Koeckritz-Blickwede, M., Nuclease expression by staphylococcus aureus facilitates escape from neutrophil extracellular traps. J. Innate Immun. 2:6 (2010), 576–586.
138. Cuenca, A.G., Delano, M.J., Kelly-Scumpia, K.M., Moreno, C., Scumpia, P.O., Laface, D.M., Heyworth, P.G., Efron, P.A., Moldawer, L.L., A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol. Med. 17:3–4 (2011), 281–292.
139. Janols, H., Bergenfelz, C., Allaoui, R., Larsson, A.M., Ryden, L., Bjornsson, S., Janciauskiene, S., Wullt, M., Bredberg, A., Leandersson, K., A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J. Leukoc. Biol. 96:5 (2014), 685–693.
140. Brudecki, L., Ferguson, D.A., McCall, C.E., El Gazzar, M., Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect. Immun. 80:6 (2012), 2026–2034.
141. Mathias, B., Delmas, A.L., Ozrazgat-Baslanti, T., Vanzant, E.L., Szpila, B.E., Mohr, A.M., Moore, F.A., Brakenridge, S.C., Brumback, B.A., Moldawer, L.L., Efron, P.A., C. I. R. C. I. and the sepsis, human myeloid-derived suppressor cells are associated with chronic immune suppression after severe Sepsis/Septic shock. Ann. Surg. 265:4 (2017), 827–834.
142. Delano, M.J., Scumpia, P.O., Weinstein, J.S., Coco, D., Nagaraj, S., Kelly-Scumpia, K.M., O'Malley, K.A., Wynn, J.L., Antonenko, S., Al-Quran, S.Z., Swan, R., Chung, C.S., Atkinson, M.A., Ramphal, R., Gabrilovich, D.I., Reeves, W.H., Ayala, A., Phillips, J., Laface, D., Heyworth, P.G., Clare-Salzler, M., Moldawer, L.L., MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:6 (2007), 1463–1474.
143. Derive, M., Bouazza, Y., Alauzet, C., Gibot, S., Myeloid-derived suppressor cells control microbial sepsis. Intensive Care Med. 38:6 (2012), 1040–1049.
144. Jia, B., Zhao, C., Li, G., Kong, Y., Ma, Y., Wang, Q., Wang, B., Zeng, H., A novel CD48-Based analysis of sepsis-Induced mouse myeloid-Derived suppressor cell compartments. Mediators Inflamm., 2017, 2017 7521701.
145. Janols, H., Bergenfelz, C., Allaoui, R., Larsson, A.-M., Ryden, L., Bjornsson, S., Janciauskiene, S., Wullt, M., Bredberg, A., Leandersson, K., A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J. Leukoc. Biol. 96:5 (2014), 685–693.
146. Darcy, C.J., Minigo, G., Piera, K.A., Davis, J.S., McNeil, Y.R., Chen, Y., Volkheimer, A.D., Weinberg, J.B., Anstey, N.M., Woodberry, T., Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit. Care, 18(4), 2014.
147. Uhel, F., Azzaoui, I., Gregoire, M., Pangault, C., Dulong, J., Tadie, J.-M., Gacouin, A., Camus, C., Cynober, L., Fest, T., Le Tulzo, Y., Roussel, M., Tarte, K., Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis. Am. J. Respir. Crit. Care Med. 196:3 (2017), 315–327.
148. Antachopoulos, C., Roilides, E., Cytokines and fungal infections. Br. J. Haematol. 129:5 (2005), 583–596.
149. Choi, K.S., Dumler, J.S., Early induction and late abrogation of respiratory burst in A-phagocytophilum − Infected neutrophils. Hechemy, K.E., AvsicZupanc, T., Childs, J.E., Raoult, D.A., (eds.) Rickettsiology: Present and Future Directions, 2003, 488–493.
150. Waldorf, A.R., Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol. Ser. 47 (1989), 243–271.
151. Butterfield, T.A., Best, T.M., Merrick, M.A., The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J. Athl. Train. 41:4 (2006), 457–465.
152. Brown, A.E., Holzer, T.J., Andersen, B.R., Capacity of human neutrophils to kill Mycobacterium tuberculosis. The Journal of infectious diseases 156:6 (1987), 985–989.
153. Pedrosa, J., Saunders, B.M., Appelberg, R., Orme, I.M., Silva, M.T., Cooper, A.M., Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 68:2 (2000), 577–583.
154. Panteleev, A.V., Nikitina, I.Y., Burmistrova, I.A., Kosmiadi, G.A., Radaeva, T.V., Amansahedov, R.B., Sadikov, P.V., Serdyuk, Y.V., Larionova, E.E., Bagdasarian, T.R., Chernousova, L.N., Ganusov, V.V., Lyadova, I.V., Severe tuberculosis in humans correlates best with neutrophil abundance and lymphocyte deficiency and does not correlate with antigen-Specific CD4 T-Cell response. Front. Immunol., 8, 2017, 963.
155. Almeida, F.M., Ventura, T.L.B., Amaral, E.P., Ribeiro, S.C.M., Calixto, S.D., Manhaes, M.R., Rezende, A.L., Souzal, G.S., de Carvalho, I.S., Silva, E.C., da Silva, J.A., Carvalho, E.C.Q., Kritski, A.L., Lasunskaia, E.B., Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice. PLoS One, 12(3), 2017.
156. Yeremeev, V., Linge, I., Kondratieva, T., Apt, A., Neutrophils exacerbate tuberculosis infection in genetically susceptible mice. Tuberculosis 95:4 (2015), 447–451.
157. Knaul, J.K., Jorg, S., Oberbeck-Mueller, D., Heinemann, E., Scheuermann, L., Brinkmann, V., Mollenkopf, H.J., Yeremeev, V., Kaufmann, S.H., Dorhoi, A., Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 190:9 (2014), 1053–1066.
158. Tsiganov, E.N., Verbina, E.M., Radaeva, T.V., Sosunov, V.V., Kosmiadi, G.A., Nikitina, I.Y., Lyadova, I.V., Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice. J. Immunol. (Baltimore, Md.: 1950) 192:10 (2014), 4718–4727.
159. El Daker, S., Sacchi, A., Tempestilli, M., Carducci, C., Goletti, D., Vanini, V., Colizzi, V., Lauria, F.N., Martini, F., Martino, A., Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level. PLoS One, 10(4), 2015, e0123772.
160. Chavez-Galan, L., Vesin, D., Uysal, H., Blaser, G., Benkhoucha, M., Ryffel, B., Quesniaux, V.F.J., Garcia, I., Transmembrane tumor necrosis factor controls myeloid-Derived suppressor cell activity via TNF receptor 2 and protects from excessive inflammation during BCG-Induced pleurisy. Front. Immunol., 8, 2017.
161. Galani, I.E., Andreakos, E., Neutrophils in viral infections: current concepts and caveats. J. Leukoc. Biol. 98:4 (2015), 557–564.
162. Fujisawa, H., Tsuru, S., Taniguchi, M., Zinnaka, Y., Nomoto, K., Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection. J. Gen.Virol. 68:Pt 2 (1987), 425–432.
163. Kong, X., Sun, R., Chen, Y., Wei, H., Tian, Z., Gamma delta t cells drive myeloid-Derived suppressor cell-Mediated CD8(+) t cell exhaustion in hepatitis B virus-Induced immunotolerance. J. Immunol. 193:4 (2014), 1645–1653.
164. Tumpey, T.M., Garcia-Sastre, A., Taubenberger, J.K., Palese, P., Swayne, D.E., Pantin-Jackwood, M.J., Schultz-Cherry, S., Solorzano, A., Van Rooijen, N., Katz, J.M., Basler, C.F., Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79:23 (2005), 14933–14944.
165. Tate, M.D., Deng, Y.-M., Jones, J.E., Anderson, G.P., Brooks, A.G., Reading, P.C., Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 183:11 (2009), 7441–7450.
166. Allen, I.C., Scull, M.A., Moore, C.B., Holl, E.K., McElvania-TeKippe, E., Taxman, D.J., Guthrie, E.H., Pickles, R.J., Ting, J.P.Y., The NLRP3 inflammasome mediates In vivo innate immunity to influenza a virus through recognition of viral RNA. Immunity 30:4 (2009), 556–565.
167. Thomas, P.G., Dash, P., Aldridge, J.R. Jr., Ellebedy, A.H., Reynolds, C., Funk, A.J., Martin, W.J., Lamkanfi, M., Webby, R.J., Boyd, K.L., Doherty, P.C., Kanneganti, T.-D., The intracellular sensor NLRP3 mediates key innate and healing responses to influenza a virus via the regulation of caspase-1. Immunity 30:4 (2009), 566–575.
168. Zhou, J.H., Stohlman, S.A., Hinton, D.R., Marten, N.W., Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J. Immunol. 170:6 (2003), 3331–3336.
169. Tumpey, T.M., Chen, S.-H., Oakes, J.E., Lausch, R.N., Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:2 (1996), 898–904.
170. Seki, M., Kohno, S., Newstead, M.W., Zeng, X., Bhan, U., Lukacs, N.W., Kunkel, S.L., Standiford, T.J., Critical role of IL-1 receptor-Associated kinase-M in regulating chemokine-Dependent deleterious inflammation in murine influenza pneumonia. J. Immunol. 184:3 (2010), 1410–1418.
171. Stacey, M.A., Marsden, M., Pham, N.T., Clare, S., Dolton, G., Stack, G., Jones, E., Klenerman, P., Gallimore, A.M., Taylor, P.R., Snelgrove, R.J., Lawley, T.D., Dougan, G., Benedict, C.A., Jones, S.A., Wilkinson, G.W., Humphreys, I.R., Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV. Cell Host Microbe 15:4 (2014), 471–483.
172. Goh, C., Narayanan, S., Hahn, Y.S., Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?. Immunol. Rev. 255:1 (2013), 210–221.
173. O'Connor, M.A., Rastad, J.L., Green, W.R., The role of myeloid-Derived suppressor cells in viral infection. Viral Immunol. 30:2 (2017), 82–97.
174. Garg, A., Spector, S.A., HIV type 1 gp120-Induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J. Infect. Dis. 209:3 (2014), 441–451.
175. Vollbrecht, T., Roider, J., Stirner, R., Tufman, A., Huber, R.M., Bogner, J.R., Lechner, A., Bourquin, C., Draenert, R., Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. Retrovirology, 9, 2012.
176. Tumino, N., Turchi, F., Meschi, S., Lalle, E., Bordoni, V., Casetti, R., Agrati, C., Cimini, E., Montesano, C., Colizzi, V., Martini, F., Sacchi, A., In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3 zeta expression through ELF-1 inhibition. AIDS 29:18 (2015), 2397–2407.
177. Tumino, N., Bilotta, M.T., Pinnetti, C., Ammassari, A., Antinori, A., Turchi, F., Agrati, C., Casetti, R., Bordoni, V., Cimini, E., Abbate, I., Capobianchi, M.R., Martini, F., Sacchi, A., Granulocytic myeloid-Derived suppressor cells increased in early phases of primary HIV infection depending on TRAIL plasma level. Jaids-J. Acquired Immune Deficiency Syndromes 74:5 (2017), 575–582.
178. Qin, A., Cai, W., Pan, T., Wu, K., Yang, Q., Wang, N., Liu, Y., Yan, D., Hu, F., Guo, P., Chen, X., Chen, L., Zhang, H., Tang, X., Zhou, J., Expansion of monocytic myeloid-Derived suppressor cells dampens t cell function in HIV-1-Seropositive individuals. J. Virol. 87:3 (2013), 1477–1490.
179. Pallett, L.J., Gill, U.S., Quaglia, A., Sinclair, L.V., Jover-Cobos, M., Schurich, A., Singh, K.P., Thomas, N., Das, A., Chen, A., Fusai, G., Bertoletti, A., Cantrell, D.A., Kennedy, P.T., Davies, N.A., Haniffa, M., Maini, M.K., Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. Nat. Med. 21:6 (2015), 591–600.
180. Huang, A., Zhang, B., Yan, W., Wang, B., Wei, H., Zhang, F., Wu, L., Fan, K., Guo, Y., Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10. J. Immunol. (Baltimore, Md.: 1950) 193:11 (2014), 5461–5469.
181. Chen, S., Akbar, S.M.F., Abe, M., Hiasa, Y., Onji, M., Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin. Exp. Immunol. 166:1 (2011), 134–142.
182. Goh, C.C., Roggerson, K.M., Lee, H.-C., Golden-Mason, L., Rosen, H.R., Hahn, Y.S., Hepatitis C virus-Induced myeloid-Derived suppressor cells suppress NK cell IFN-gamma production by altering cellular metabolism via arginase-1. J. Immunol. 196:5 (2016), 2283–2292.
183. Zhu, J., Huang, X., Yang, Y., Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer. J. Virol. 86:24 (2012), 13689–13696.
184. De Santo, C., Salio, M., Masri, S.H., Lee, L.Y.-H., Dong, T., Speak, A.O., Porubsky, S., Booth, S., Veerapen, N., Besra, G.S., Groene, H.-J., Platt, F.M., Zambon, M., Cerundolo, V., Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 118:12 (2008), 4036–4048.
185. Jeisy-Scott, V., Davis, W.G., Patel, J.R., Bowzard, J.B., Shieh, W.-J., Zaki, S.R., Katz, J.M., Sambhara, S., Increased MDSC accumulation and th2 biased response to influenza a virus infection in the absence of TLR7 in mice. PLoS One, 6(9), 2011.
186. Fortin, C., Huang, X., Yang, Y., NK cell response to vaccinia virus is regulated by myeloid-Derived suppressor cells. J. Immunol. 189:4 (2012), 1843–1849.
187. Heim, C.E., Vidlak, D., Scherr, T.D., Hartman, C.W., Garvin, K.L., Kielian, T., IL-12 promotes myeloid-Derived suppressor cell recruitment and bacterial persistence during staphylococcus aureus orthopedic implant infection. J. Immunol., 194(8), 2015 (3861-+.).
188. Heim, C.E., Vidlak, D., Scherr, T.D., Kozel, J.A., Holzapfel, M., Muirhead, D.E., Kielian, T., Myeloid-Derived suppressor cells contribute to staphylococcus aureus orthopedic biofilm infection. J. Immunol. 192:8 (2014), 3778–3792.
189. Peng, K.-T., Hsieh, C.-C., Huang, T.-Y., Chen, P.-C., Shih, H.-N., Lee, M.S., Chang, P.-J., Staphylococcus aureus biofilm elicits the expansion, activation and polarization of myeloid-derived suppressor cells in vivo and in vitro. PLoS One, 12(8), 2017.
190. du Plessis, N., Loebenberg, L., Kriel, M., von Groote-Bidlingmaier, F., Ribechini, E., Loxton, A.G., van Helden, P.D., Lutz, M.B., Walzl, G., Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-Cell function. Am. J. Respir. Crit. Care Med. 188:6 (2013), 724–732.
191. Knaul, J.K., Joerg, S., Oberbeck-Mueller, D., Heinemann, E., Scheuermann, L., Brinkmann, V., Mollenkopf, H.-J., Yeremeev, V., Kaufmann, S.H.E., Dorhoi, A., Lung-Residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 190:9 (2014), 1053–1066.
192. Oz, H.H., Zhou, B., Voss, P., Careyic, M., Schroth, C., Frey, N., Rieber, N., Hector, A., Hartl, D., Pseudomonas aeruginosa airway infection recruits and modulates neutrophilic myeloid-Derived suppressor cells. Front. Cell. Infect. Microbiol., 6, 2016.
193. Poe, S.L., Arora, M., Oriss, T.B., Yarlagadda, M., Isse, K., Khare, A., Levy, D.E., Lee, J.S., Mallampalli, R.K., Chan, Y.R., Ray, A., Ray, P., STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol. 6:1 (2013), 189–199.
194. Sander, L.E., Sackett, S.D., Dierssen, U., Beraza, N., Linke, R.P., Mueller, M., Blander, J.M., Tacke, F., Trautwein, C., Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207:7 (2010), 1453–1464.
195. Cuenca, A.G., Cuenca, A.L., Winfield, R.D., Joiner, D.N., Gentile, L., Delano, M.J., Kelly-Scumpia, K.M., Scumpia, P.O., Matheny, M.K., Scarpace, P.J., Vila, L., Efron, P.A., LaFace, D.M., Moldawer, L.L., Novel role for tumor-Induced expansion of myeloid-Derived cells in cancer cachexia. J. Immunol. 192:12 (2014), 6111–6119.
196. Dietlin, T.A., Hofman, F.M., Lund, B.T., Gilmore, W., Stohlman, S.A., van der Veen, R.C., Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion. J. Leukoc. Biol. 81:5 (2007), 1205–1212.